Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T W Barrowcliffe

Showing results (21-30 of 159) with videos related to

Pageof 16
Sort By:
Thrombosis Research|May 15, 1986
Lipolytic activities of low molecular weight heparinsT W Barrowcliffe
Thrombosis and Haemostasis|April 8, 1988
International Committee Communications. Standardization and clinical use of LMW heparin. Report of the ICTH Heparin Subcommittee, Brussels, July 1987J Hirsh, T W Barrowcliffe
Thrombosis Research|January 15, 1985
Inhibition of antithrombin III by lipid peroxidesE Gray, T W Barrowcliffe
Thrombosis Et Diathesis Haemorrhagica|December 15, 1975
Letter: The buffering of anticoagulants for blood collectionR Godfrey, T W Barrowcliffe
Thrombosis and Haemostasis|October 1, 1981
Studies of phospholipid reagents used in coagulation I: some general properties and their sensitivity to factor VIIIT W Barrowcliffe, E Gray
Thrombosis and Haemostasis|October 1, 1981
Studies of phospholipid reagents used in coagulation II: factors influencing their sensitivity to heparinT W Barrowcliffe, E Gray
British Journal of Haematology|July 1, 1986
Factor VIII concentrates contain factor VIII procoagulant antigen bound to phospholipidG Kemball-Cook, T W Barrowcliffe
British Journal of Haematology|November 1, 1980
Standardization of Factor VIII. I. Calibration of British Standards for Factor VIII clotting activityT W Barrowcliffe, T B Kirkwood
Thrombosis Research|July 1, 1992
Interaction of factor VIII with phospholipids: role of composition and negative chargeG Kemball-Cook, T W Barrowcliffe
British Journal of Haematology|August 1, 1984
Fractionation of human antibody to factor VIII:C: and IRMA for phospholipid binding sites on factor VIII C:AgG Kemball-Cook, T W Barrowcliffe
Pageof 16

Showing results (21-30 of 159) with videos related to

Sort By:
Pageof 16
Thrombosis Research|May 15, 1986
Lipolytic activities of low molecular weight heparinsT W Barrowcliffe
Thrombosis and Haemostasis|April 8, 1988
International Committee Communications. Standardization and clinical use of LMW heparin. Report of the ICTH Heparin Subcommittee, Brussels, July 1987J Hirsh, T W Barrowcliffe
Thrombosis Research|January 15, 1985
Inhibition of antithrombin III by lipid peroxidesE Gray, T W Barrowcliffe
Thrombosis Et Diathesis Haemorrhagica|December 15, 1975
Letter: The buffering of anticoagulants for blood collectionR Godfrey, T W Barrowcliffe
Thrombosis and Haemostasis|October 1, 1981
Studies of phospholipid reagents used in coagulation I: some general properties and their sensitivity to factor VIIIT W Barrowcliffe, E Gray
Thrombosis and Haemostasis|October 1, 1981
Studies of phospholipid reagents used in coagulation II: factors influencing their sensitivity to heparinT W Barrowcliffe, E Gray
British Journal of Haematology|July 1, 1986
Factor VIII concentrates contain factor VIII procoagulant antigen bound to phospholipidG Kemball-Cook, T W Barrowcliffe
British Journal of Haematology|November 1, 1980
Standardization of Factor VIII. I. Calibration of British Standards for Factor VIII clotting activityT W Barrowcliffe, T B Kirkwood
Thrombosis Research|July 1, 1992
Interaction of factor VIII with phospholipids: role of composition and negative chargeG Kemball-Cook, T W Barrowcliffe
British Journal of Haematology|August 1, 1984
Fractionation of human antibody to factor VIII:C: and IRMA for phospholipid binding sites on factor VIII C:AgG Kemball-Cook, T W Barrowcliffe
Pageof 16